HIV-1 Vpr activates cell cycle inhibitor p21/Waf1/Cip1: A potential mechanism of G2/M cell cycle arrest

被引:57
作者
Chowdhury, IH
Wang, XF
Landau, NR
Robb, ML
Polonis, VR
Birx, DL
Kim, JH
机构
[1] Henry M Jackson Fdn Advancement Mil Med, Div Retrovirol, Rockville, MD 20850 USA
[2] Duke Univ, Med Ctr, Dept Pharmacol, Durham, NC 27710 USA
[3] Salk Inst Biol Studies, Infect Dis Lab, La Jolla, CA 92037 USA
[4] Walter Reed Army Inst Res, Div Retrovirol, Rockville, MD 20850 USA
关键词
HIV-1; Vpr; cell cycle; G2/M phase; cdk; p21; transcription; p53;
D O I
10.1006/viro.2002.1777
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The Vpr gene of human immunodeficiency virus type 1 (HIV-1) encodes a 14-kDa protein that prevents cell proliferation by causing arrest in the G2/M phase of the cell cycle. Here we report the first evidence that Vpr activates the expression and transcription of the cyclin-dependent kinase inhibitor p21/Waf1/Cip1 (hereafter p21), an inhibitor of the G1 and G2/M phase transitions in T lymphoid and myeloid cells. Vpr activated p21 protein expression in a dose-dependent manner. Vpr also caused a three- to eightfold induction of the p21 promoter. This induction was dose- and time-dependent and was comparable to levels of p21 induction induced by p53. Of note, Vpr activated p21 transcription in endogenous p53 positive cells, but not in p53-deleted or p53 nonfunctional cells. Vpr and p53 had an additive effect on p21 transcription. Mutational analysis indicated that wt Vpr, but not cell cycle inactive Vpr mutants, activated the p21 promoter. These data demonstrate that HIV-1 Vpr utilizes the cyclin-dependent kinase inhibitor p21, in addition to cdc2, to arrest cells in G2/M. (C) 2003 Elsevier Science (USA).
引用
收藏
页码:371 / 377
页数:7
相关论文
共 45 条
[1]   Involvement of the interaction between p21 and proliferating cell nuclear antigen for the maintenance of G2/M arrest after DNA damage [J].
Ando, T ;
Kawabe, T ;
Ohara, H ;
Ducommun, B ;
Itoh, M ;
Okamoto, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (46) :42971-42977
[2]   ANTISENSE PHOSPHOROTHIOATE OLIGODEOXYNUCLEOTIDES TARGETED TO THE VPR GENE INHIBIT HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN PRIMARY HUMAN MACROPHAGES [J].
BALOTTA, C ;
LUSSO, P ;
CROWLEY, R ;
GALLO, RC ;
FRANCHINI, G .
JOURNAL OF VIROLOGY, 1993, 67 (07) :4409-4414
[3]   Requirement for p53 and p21 to sustain G2 arrest after DNA damage [J].
Bunz, F ;
Dutriaux, A ;
Lengauer, C ;
Waldman, T ;
Zhou, S ;
Brown, JP ;
Sedivy, JM ;
Kinzler, KW ;
Vogelstein, B .
SCIENCE, 1998, 282 (5393) :1497-1501
[4]   INACTIVATION OF P53 GENE IN HUMAN AND MURINE OSTEOSARCOMA CELLS [J].
CHANDAR, N ;
BILLIG, B ;
MCMASTER, J ;
NOVAK, J .
BRITISH JOURNAL OF CANCER, 1992, 65 (02) :208-214
[5]   vif-Negative human immunodeficiency virus type 1 persistently replicates in primary macrophages, producing attenuated progeny virus [J].
Chowdhury, IH ;
Chao, W ;
Potash, MJ ;
Sova, P ;
Gendelman, HE ;
Volsky, DJ .
JOURNAL OF VIROLOGY, 1996, 70 (08) :5336-5345
[6]  
COHEN EA, 1990, J ACQ IMMUN DEF SYND, V3, P11
[7]   HUMAN-IMMUNODEFICIENCY-VIRUS VPR PRODUCT IS A VIRION-ASSOCIATED REGULATORY PROTEIN [J].
COHEN, EA ;
DEHNI, G ;
SODROSKI, JG ;
HASELTINE, WA .
JOURNAL OF VIROLOGY, 1990, 64 (06) :3097-3099
[8]   VPR IS REQUIRED FOR EFFICIENT REPLICATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN MONONUCLEAR PHAGOCYTES [J].
CONNOR, RI ;
CHEN, BK ;
CHOE, S ;
LANDAU, NR .
VIROLOGY, 1995, 206 (02) :935-944
[9]   TRANSFORMING GROWTH-FACTOR-BETA INDUCES THE CYCLIN-DEPENDENT KINASE INHIBITOR P21 THROUGH A P53-INDEPENDENT MECHANISM [J].
DATTO, MB ;
LI, Y ;
PANUS, JF ;
HOWE, DJ ;
XIONG, Y ;
WANG, XF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (12) :5545-5549
[10]   MUTATIONAL ANALYSIS OF CELL-CYCLE ARREST, NUCLEAR-LOCALIZATION, AND VIRION PACKAGING OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VPR [J].
DIMARZIO, P ;
CHOE, S ;
EBRIGHT, M ;
KNOBLAUCH, R ;
LANDAU, NR .
JOURNAL OF VIROLOGY, 1995, 69 (12) :7909-7916